Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3042]
News [6141]
Articles [120]
Editorials [18]
Conferences [181]
elearning [32]
FDA approves palbociclib for treatment of ER-positive, HER2-negative advanced breast cancer in postmenopausal women
FDA approves palbociclib for treatment of ER-positive, HER2-negative advanced breast cancer in postmenopausal women
Nivolumab approved by the FDA for melanoma treatment
Nivolumab approved by the FDA for melanoma treatment
Ibrutinib approved by FDA for Waldenstrom’s macroglobulinemia
Ibrutinib approved by FDA for Waldenstrom’s macroglobulinemia
World leaders gathering at Davos face calls for bold action to turn the tide on cancer
World leaders gathering at Davos face calls for bold action to turn the tide on cancer
Call for reinstatement of 'last resort' life-extending cancer drug to UK cancer drug list
Call for reinstatement of 'last resort' life-extending cancer drug to UK cancer drug list
Disappointment over NHS England's bowel cancer drug decision
Disappointment over NHS England's bowel cancer drug decision
CHMP opinion recommends bortezomib for use in mantle cell lymphoma
CHMP opinion recommends bortezomib for use in mantle cell lymphoma
European call for action on cancer immunotherapies
European call for action on cancer immunotherapies
Olaparib approved in the EU as treatment for advanced BCRA-mutated ovarian cancer
Olaparib approved in the EU as treatment for advanced BCRA-mutated ovarian cancer
ASH 2014: Low-molecular-weight heparin more effective than warfarin in preventing clot recurrence in cancer patients
ASH 2014: Low-molecular-weight heparin more effective than warfarin in preventing clot recurrence in cancer...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation